Tel Aviv - Delayed Quote ILA

Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

Compare
185.60
-6.60
(-3.43%)
At close: January 26 at 3:49:34 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.
NameTitlePayExercisedYear Born
Mr. Aviad Bossi Chief Executive Officer 1.03M -- 1976
Ms. Nega Kebbia Hon Vice President of Information Systems 1M -- 1973
Mr. Assi Weshler Chief Executive Officer of Trilog & Medicare to Home 2.25M -- --
Mr. Yehiel Asia Chief Executive Officer of Ein Tal 1.25M -- --
Mr. Rafi Friedman Chief Executive Officer of Mediplast Israel Ltd. 1.19M -- 1963
Mr. Yaniv Vidavsky Chief Financial Officer -- -- 1970
Adi Marx Vice President of Business Development & Special Projects -- -- 1989
Ms. Gali Srogati Vice President of Human Resources -- -- --
David Shmuelov Chief Executive Officer of Drug Distribution & Medical Device Company -- -- 1972
Mr. Amitai Gridish Chief Executive Officer of Target Care Services Ltd. -- -- 1985

Novolog (Pharm-Up 1966) Ltd

55 Ma'ayan Street
Modi'in-Maccabim-Re'ut, 7171301
Israel
972 8 660 4400 https://www.novolog.co.il
Sector: 
Healthcare
Full Time Employees: 
955

Description

Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Health Services, and Digital. The Logistics division engages in the import and distribution of medicine and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Health Services division provides customized medicine, medical and diagnostic laboratory, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics, doctors therapists, and medical bodies; provides services and management tools; and operates and markets digital platforms for doctors and clinics. Novolog (Pharm-Up 1966) Ltd was incorporated in 1966 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.

Corporate Governance

Novolog (Pharm-Up 1966) Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

December 2, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

ILM1.DE Medios AG
12.08
+1.51%
 
ARJO-B.ST Arjo AB (publ)
37.20
-0.69%
 
CYC.AX Cyclopharm Limited
2.3600
+3.96%
 
1099.HK SINOPHARM
20.100
0.00%
 
HSIC Henry Schein, Inc.
74.97
+0.29%
 
COR Cencora, Inc.
248.48
+0.22%
 
COSM Cosmos Health Inc.
0.7836
-0.66%
 
CAH Cardinal Health, Inc.
128.83
-0.36%
 
MCK McKesson Corporation
591.58
-0.94%